5 completed, 2 unknown, 1 not yet recruiting. 8 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 8 | Completed 5, Unknown 2, Not yet recruiting 1 |
Follow roxadustat: new trials by email Literature Review of roxadustat trials Research Report on roxadustat
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitors on Sarcopenia in Hemodialysis Patients Roxadustat, Recombinant human erythropoietin (EPO) - Sarcopenia, Anemia Associated With Chronic Kidney Disease (CKD) | Phase 4 | Not yet recruiting | Tianjin Medical University General Hospital | 60 | 2025-09-10 | 2025-09-09 |
| Roxadustat Combined With Luspatercept Versus Luspatercept Monotherapy in the Treatment of Refractory MDS-RS Roxadustat, Luspatercept - Myelodysplastic Syndromes | Phase 4 | Unknown | Peking Union Medical College Hospital | 62 | 2023-08-01 | 2023-08-23 |
| Effect of Low Doses of Hypoxia-inducible Factor- Prolyl Hydroxylase Enzyme Inhibitor Plus Iron in the Treatment of Anemia in Dialysis-dependent Chronic Kidney Disease Patients Roxadustat - Anemia in Dialysis-dependent CKD Patients | Phase 4 | Completed | Alexandria University | 72 | 2023-05-24 | 2026-06-24 |
| Study of the Safety and Efficacy of Roxadustat in the Treatment of Heart Failure With Chronic Kidney Disease and Anemia Roxadustat, Recombinant human eythropoietin and/or Iron agents - Heart Failure, Chronic Kidney Diseases | Phase 4 | Unknown | China-Japan Friendship Hospital | 300 | 2023-02-01 | 2023-01-20 |
| Study of Roxadustat's Effect on Anemia in Patients With Diabetic Kidney Disease Roxadustat - Diabetic Kidney Disease, Anemia | Phase 4 | Completed | Second Xiangya Hospital of Central South University | 124 | 2021-11-02 | 2026-01-26 |
| A Study to Investigate the Effect of Roxadustat Versus Recombinant Human Erythropoietin (rHuEPO) on Oral Iron Absorption in Chinese Patients With Anemia of Chronic Kidney Disease (CKD) Roxadustat, rHuEPO - Anemia of Chronic Kidney Disease | Phase 4 | Completed | AstraZeneca | 25 | 2021-02-22 | 2024-04-22 |
| Different Doses of Roxadustat Treatment for Anemia in Peritoneal Dialysis Patients Roxadustat - Renal Anemia | Phase 4 | Completed | Peking University First Hospital | 100 | 2020-07-01 | 2021-11-26 |
| Evaluate the Efficacy and Safety of Multiple Roxadustat Dosing Regimens for the Treatment of Anemia in Dialysis Participants With Chronic Kidney Disease Roxadustat - CKD Anemia in Dialysis Participants | Phase 4 | Completed | Kyntra Bio | 318 | 2019-06-11 | 2022-05-06 |
Anemia (5) · Renal Insufficiency, Chronic (2) · Diabetic Nephropathies (1) · Heart Failure (1) · Kidney Failure, Chronic (1) · Myelodysplastic Syndromes (1) · Sarcopenia (1)
Alexandria University (1) · AstraZeneca (1) · China-Japan Friendship Hospital (1) · Kyntra Bio (1) · Peking Union Medical College Hospital (1) · Peking University First Hospital (1) · Second Xiangya Hospital of Central South University (1) · Tianjin Medical University General Hospital (1)
China (5) · Egypt (1)
Jie Dong, MD (1) · Li Xuemei (1) · Lin Sun, doctor (1)
PMID 35257058, PMID 35806119, PMID 36005278, PMID 36364144, PMID 37812446, PMID 38280066, PMID 38333911